Novavax, Inc. (NVAX)
Novavax, Inc. (NVAX) is a healthcare company (biotechnology) based in the United States. The share price is $7.98, down 1.05% on the day, which values the company at $1.32B. Price as of 17 Nov 2026, 20:53 UTC, from Yahoo Finance.
Key facts
- Share price
- $7.98−1.05% today
- Market value
- $1.32B
- Funk Score
- 55/100
- 200-week average
- $8.385% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Novavax, Inc. in more detail
NVAX trades at -44.3× next year's expected earnings, 3.2× sales. It sits 5% below its 200-week average of $8.38.
Over the last five fiscal years Novavax, Inc. has compounded revenue 18.8% a year. Its Funk Score is 55 out of 100 (financial strength 7.1, profitability 5.3, growth 5.8, value 3.8, each out of 10).
In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.
1 of the superinvestors tracked here hold NVAX, including Philippe Laffont (0.1% of the portfolio).
Superinvestors holding NVAX
1 of the investors tracked here report a position in their latest 13F filing.
- Philippe Laffont Coatue Management0.08% of portfolio · $41.5M · Q3 2026
Novavax, Inc. (NVAX): questions and answers
What is NVAX's PEG ratio?
Novavax, Inc.'s PEG ratio is 1.32 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Novavax, Inc.'s market cap?
Novavax, Inc. is valued at $1.32B at a share price of $7.98.
Is NVAX above its 200-week moving average?
No. NVAX is 4.8% below its 200-week average of $8.38. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Novavax, Inc. growing?
Over the last five fiscal years Novavax, Inc.'s revenue grew 18.8% a year; over ten years revenue grew 41.0% a year.
Does NVAX pay a dividend?
Novavax, Inc. does not currently pay a regular dividend.
Which famous investors own NVAX?
In their latest quarterly filings, Philippe Laffont (0.1% of the portfolio) hold NVAX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Novavax, Inc. (NVAX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NVAX
Underlying data: Yahoo Finance; company filings with the SEC.